Publicação: Incidence and impact of activating mutations of the RAS-RAF- MEK-ERK pathway in patients with philadelphia-negative (Ph-negative) myeloproliferative neoplasms (MPNs) and myelodysplastic/myeloproliferative disorders-unclassified (MDS/MPD-U)
dc.contributor.author | Santos, Fabio P. S. | |
dc.contributor.author | Lisboa, Bianca | |
dc.contributor.author | Datoguia, Tarcila S. | |
dc.contributor.author | Helman, Ricardo | |
dc.contributor.author | Pereira, Welbert Oliveira | |
dc.contributor.author | Puga, Renato D. | |
dc.contributor.author | Miyagi, Mariana | |
dc.contributor.author | Mata, Evelyn H. A. da | |
dc.contributor.author | Santucci, Rodrigo | |
dc.contributor.author | Perini, Guilherme F. | |
dc.contributor.author | Souto, Eizabeth Xisto | |
dc.contributor.author | Kassab, Carolina | |
dc.contributor.author | Padua, Leandro | |
dc.contributor.author | Bollman, Patricia W. | |
dc.contributor.author | Higashi, Marcia | |
dc.contributor.author | Soares, Rodolfo | |
dc.contributor.author | Fadel, Adriana Valente [UNESP] | |
dc.contributor.author | Musacchio, Juliane | |
dc.contributor.author | Schriefer, Ana Fernandes | |
dc.contributor.author | Salvino, Marco Aurelio | |
dc.contributor.author | Cordeiro De Farias, Danielle Leao | |
dc.contributor.author | Perobelli, Leila Martins | |
dc.contributor.author | Costa, Erika M. M. | |
dc.contributor.author | Lima, Marinus M. | |
dc.contributor.author | Mattos, Vinicius R. P. | |
dc.contributor.author | Silveira, Paulo A. A. | |
dc.contributor.author | Bacal, Nydia | |
dc.contributor.author | Guerra, Joao Carlos | |
dc.contributor.author | Bezerra, Alanna Mara P. S. | |
dc.contributor.author | Pasqualin, Denise da Cunha | |
dc.contributor.author | Bello, Isabel C. | |
dc.contributor.author | Diniz, Michelli Silva | |
dc.contributor.author | Nakashima, Sandra S. | |
dc.contributor.author | Velloso, Elvira | |
dc.contributor.author | Hamerschlak, Nelson | |
dc.contributor.author | Campregher, Paulo Vidal | |
dc.contributor.institution | Hosp Israelita Albert Einstein | |
dc.contributor.institution | HEMOMED | |
dc.contributor.institution | Hosp Brigadeiro | |
dc.contributor.institution | Ctr Hematol Sao Paulo | |
dc.contributor.institution | Hosp Leforte | |
dc.contributor.institution | Hosp Mario Covas | |
dc.contributor.institution | Fundacao Hosp Amaral Carvalho | |
dc.contributor.institution | Univ Fed Rio Grande do Norte | |
dc.contributor.institution | Universidade Estadual Paulista (Unesp) | |
dc.contributor.institution | Clin Oncol Integrada | |
dc.contributor.institution | Universidade Federal da Bahia (UFBA) | |
dc.contributor.institution | Universidade Federal de Goiás (UFG) | |
dc.date.accessioned | 2015-11-03T18:24:51Z | |
dc.date.available | 2015-11-03T18:24:51Z | |
dc.date.issued | 2014-12-06 | |
dc.description.affiliation | Hosp Israelita Albert Einstein, Sao Paulo, Brazil | |
dc.description.affiliation | HEMOMED, Sao Paulo, Brazil | |
dc.description.affiliation | Hosp Brigadeiro, Sao Paulo, Brazil | |
dc.description.affiliation | Ctr Hematol Sao Paulo, Sao Paulo, Brazil | |
dc.description.affiliation | Hosp Leforte, Sao Paulo, Brazil | |
dc.description.affiliation | Hosp Mario Covas, Santo Andre, Brazil | |
dc.description.affiliation | Fundacao Hosp Amaral Carvalho, Jau, Brazil | |
dc.description.affiliation | Univ Fed Rio Grande do Norte, Nucleo Hematol Hemoterapia, BR-59072970 Natal, RN, Brazil | |
dc.description.affiliation | UNESP, Botucatu, SP, Brazil | |
dc.description.affiliation | Clin Oncol Integrada, Rio De Janeiro, Brazil | |
dc.description.affiliation | Univ Fed Bahia, Salvador, BA, Brazil | |
dc.description.affiliation | Univ Fed Goias, Hosp Clin, Goiania, Go, Brazil | |
dc.description.affiliationUnesp | UNESP, Botucatu, SP, Brazil | |
dc.format.extent | 1-4 | |
dc.identifier | http://www.bloodjournal.org/content/124/21/3172 | |
dc.identifier.citation | Blood. Washington: Amer Soc Hematology, v. 124, n. 21, p. 1-4, 2014. | |
dc.identifier.issn | 0006-4971 | |
dc.identifier.uri | http://hdl.handle.net/11449/130344 | |
dc.identifier.wos | WOS:000349243503205 | |
dc.language.iso | eng | |
dc.publisher | Amer Soc Hematology | |
dc.relation.ispartof | Blood | |
dc.relation.ispartofjcr | 15.132 | |
dc.relation.ispartofsjr | 6,434 | |
dc.rights.accessRights | Acesso aberto | |
dc.source | Web of Science | |
dc.title | Incidence and impact of activating mutations of the RAS-RAF- MEK-ERK pathway in patients with philadelphia-negative (Ph-negative) myeloproliferative neoplasms (MPNs) and myelodysplastic/myeloproliferative disorders-unclassified (MDS/MPD-U) | en |
dc.type | Resumo | |
dcterms.rightsHolder | Amer Soc Hematology | |
dspace.entity.type | Publication | |
unesp.author.orcid | 0000-0002-5140-5310[35] | |
unesp.author.orcid | 0000-0002-9707-0579[34] | |
unesp.campus | Universidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatu | pt |
unesp.department | Clínica Médica - FMB | pt |